Impact BioMedical, Inc. — Institutional Ownership
Which tracked institutions hold IBO, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
8
Funds holding
$513006
Total value held
Buying
2 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | State Street Corp | $279633 | 607897 | — | Held |
| 2 | Blackrock, Inc. | $119575 | 259946 | — | Held |
| 3 | Northern Trust Corp | $108319 | 235475 | -8468 | -3.47% |
| 4 | Morgan Stanley | $4272 | 9285 | +11 | +0.12% |
| 5 | Ubs Group Ag | $1104 | 2400 | +2400 | NEW BUY |
| 6 | Wells Fargo & Company/Mn | $103 | 224 | — | Held |
| 7 | Citigroup Inc | $0 | 1 | — | Held |
| 8 | Royal Bank Of Canada | $0 | 32 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.